Orrick Advises Ipsen on Acquisition of Epizyme
| June.27.2022

The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.
| June.27.2022
The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.
| June.06.2022
Returning investor OMERS Growth Equity led the round, which also included Fidelity Management & Research Company and other current investors.
| June.06.2022
| May.24.2022
Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc.
| May.03.2022
| March.09.2022
Orrick advises Twist Bioscience on upsized public offering of common stock.
| January.21.2022
| December.17.2021
| September.24.2021
| August.26.2021
| July.26.2021
| July.20.2021
| June.21.2021
by Gargi Talukder, Jessica Stern, Alex Straughn and Jennifer Ng | June.22.2022
| April.26.2022
by Thora Johnson, Gargi Talukder, David Rhinesmith and Matthew Reeder | April.26.2022
| February.16.2022
by Thora Johnson, Shannon Yavorsky, David Curtis, Melanie Phillips and Alyssa Wolfington | January.27.2022
by Rob McKenna, Brian T. Moran, Andrew Cook and Erica Sechrist | December.17.2021
| October.19.2021
by Thora Johnson, Heather Sussman and Ryan McKenney | September.27.2021
by Thora Johnson, Emily S. Tabatabai, Hannah Levin and Melanie Phillips | September.23.2021
by Thora Johnson, Adele Harrison and Hannah Levin | July.22.2021
| July.21.2021
| April.20.2021
| February.01.2021
by Peter M. Lamb, David M. Ruff, Hari Raman, Daniel Lopez and Zac Padgett | January.21.2021
by Dr. Oliver Duys LL.M. (UNSW Sydney) and Abhijit Narayan | August.17.2020
| May.31.2022
Congratulations to Orrick partner Gregg Griner on being recognized as a Go-To Lawyer for Healthcare and Life Sciences by Massachusetts Lawyers Weekly.
| February.22.2022
| January.03.2022
| October.11.2021
Orrick welcomes Franklin Monsour, a former federal prosecutor and experienced white collar and regulatory adviser to the life sciences sector.
| September.27.2021
| July.07.2021